These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8767066)

  • 1. [Current indications for the treatment with angiotensin-converting enzyme inhibitors].
    Orte Martínez LM
    Rev Clin Esp; 1996 Jun; 196(6):345-6. PubMed ID: 8767066
    [No Abstract]   [Full Text] [Related]  

  • 2. [What is assured in therapy with angiotensin converting enzyme (ACE) inhibitors?].
    Risler T; Krämer B; Müller GA; Seipel L
    Internist (Berl); 1989 Dec; 30(12):790-6. PubMed ID: 2695488
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of hypertension.
    Fogo A; Kon V
    Semin Nephrol; 1996 Nov; 16(6):555-66. PubMed ID: 9125800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The practical aspects of combination therapy with angiotensin receptor blockers and angiotensin-converting enzyme inhibitors.
    Sica DA
    J Renin Angiotensin Aldosterone Syst; 2002 Jun; 3(2):66-71. PubMed ID: 12228845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Angiotensin converting enzyme inhibitors for hypertension].
    Kobusiak-Prokopowicz M
    Pol Merkur Lekarski; 1997 Jan; 2(7):66-70. PubMed ID: 9296907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive treatment and glomerular size selectivity in hypertensive patients with renal parenchymal disease and proteinuria.
    Shand BI; Lewis JG; Elder PA; Agarwal M
    Clin Nephrol; 2002 Oct; 58(4):321-4. PubMed ID: 12400851
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical inquiries. What are the indications for treatment with angiotensin-converting enzyme (ACE) inhibitors in patients with diabetes?
    Loomis LW; Quint A
    J Fam Pract; 2001 Oct; 50(10):842-3. PubMed ID: 11674883
    [No Abstract]   [Full Text] [Related]  

  • 8. Chronic kidney disease: tipping the scale to the benefit of angiotensin-converting enzyme inhibitors in patients with coronary artery disease.
    McCullough PA
    Circulation; 2006 Jul; 114(1):6-7. PubMed ID: 16818827
    [No Abstract]   [Full Text] [Related]  

  • 9. [Angiotensin-converting enzyme inhibitors. Familiar drugs--new indications].
    Gregor P
    Cas Lek Cesk; 1998 Mar; 137(5):150-3. PubMed ID: 9588098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reply to the letter from G. Smith. Angiotensin converting enzyme inhibitor (ACEI) and reflux nephropathy.
    Lama G; Salsano ME; Pedullà M; Grassia C; Ruocco G
    Pediatr Nephrol; 1999 Aug; 13(6):552. PubMed ID: 10452288
    [No Abstract]   [Full Text] [Related]  

  • 11. How should renin-angiotensin system blockade be applied in chronic kidney disease for optimal renal protection?
    Zhang X; Hou FF
    Chin Med J (Engl); 2007 Feb; 120(3):243-5. PubMed ID: 17355830
    [No Abstract]   [Full Text] [Related]  

  • 12. [Angiotensin converting enzyme inhibitors. Increasing importance in the treatment of hypertension].
    Januszewicz A; Lapiński M
    Kardiol Pol; 1992 Dec; 37(12):393-7. PubMed ID: 1293350
    [No Abstract]   [Full Text] [Related]  

  • 13. [Converting enzyme inhibitors and arterial hypertension].
    Mimran A
    Rev Prat; 1988 Mar; 38(10):604-12. PubMed ID: 3375762
    [No Abstract]   [Full Text] [Related]  

  • 14. Evolving understanding of the renin-angiotensin-aldosterone system: pathophysiology and targets for therapeutic intervention.
    Gradman AH
    Am Heart J; 2009 Jun; 157(6 Suppl):S1-6. PubMed ID: 19450719
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical aspects of use of angiotensin-converting enzyme inhibitors in patients with arterial hypertension].
    Widimský J
    Cas Lek Cesk; 1998 Mar; 137(6):175-8. PubMed ID: 9588103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Kjeldsen SE; Julius S
    Am Heart J; 2004 Nov; 148(5):747-54. PubMed ID: 15523303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managing hypertension using combination therapy.
    Frank J
    Am Fam Physician; 2008 May; 77(9):1279-86. PubMed ID: 18540493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal effects of angiotensin-converting enzyme inhibitors that result in cost savings and improved patient outcomes.
    Swislocki AL; Siegel D
    Am J Manag Care; 2001 Mar; 7(3):283-95. PubMed ID: 11258145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is scleroderma renal crisis with anti-centromere antibody-positive limited cutaneous systemic sclerosis overlooked in patients with hypertension and/or renal dysfunction?
    Sugimoto T; Sanada M; Kashiwagi A
    Nephrology (Carlton); 2008 Apr; 13(2):179-80. PubMed ID: 18275510
    [No Abstract]   [Full Text] [Related]  

  • 20. [ACE-inhibitors in renal protection].
    Barna I
    Orv Hetil; 2006 Jun; 147(22):1019-23. PubMed ID: 16913091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.